Advertisement
Home »

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.

Jan 16, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE EXPERTS

  • Michael A Thompson

    Aurora Cancer Care, Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI,. Electronic address: michael.thompson@tempus.com.

    Mario Boccadoro

    Division of Hematology, University of Torino, Torino, Italy.

    Xavier Leleu

    Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, France.

    Jorge Vela-Ojeda

    Department of Hematology, UMAE Hospital de Especialidades Centro Medico La Raza IMSS, Mexico City, Mexico.

    Frits van Rhee

    University of Arkansas for Medical Sciences, Little Rock, AR.

    Katja C Weisel

    University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

    Robert M Rifkin

    Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO.

    Saad Z Usmani

    Levine Cancer Institute, Charlotte, NC.

    Roman Hájek

    Department of Hemato-oncology, University Hospital Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

    Gordon Cook

    Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK.

    Rafat Abonour

    Indiana University School of Medicine, Indianapolis, IN.

    Mira Armour

    Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia.

    Kathryn E Morgan

    Myeloma Patients Europe, Brussels, Belgium.

    Su-Peng Yeh

    China Medical University Hospital, Taichung City, P.R.China.

    Caitlin L Costello

    University of California San Diego, La Jolla, CA.

    Jesus G Berdeja

    Department of Hematology, Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN.

    Faith E Davies

    Perlmutter Cancer Center, NYU Langone, New York, NY.

    Jeffrey A Zonder

    Department of Malignant Hematology, Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI.

    Hans C Lee

    Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

    Jim Omel

    The Central Nebraska Myeloma Support Group, Grand Island, NE.

    Andrew Spencer

    Malignant Haematology and Stem Cell Transplantation Service, Alfred Health Monash University, Melbourne, Australia.

    Evangelos Terpos

    Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

    Vania T M Hungria

    Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil.

    Noemi Puig

    Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain.

    Chengcheng Fu

    First Affiliated Hospital, Soochow University, Suzhou Jiangsu, P.R.China.

    Renda H Ferrari

    Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA.

    Kaili Ren

    Takeda Development Center Americas, Inc. (TDCA), Lexington, MA.

    Dawn Marie Stull

    Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA.

    Ajai Chari

    Department of Hematology-Oncology, Mount Sinai School of Medicine, New York, NY.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement